Literature DB >> 9595853

Subependymal giant cell astrocytoma: clinical, histologic and immunohistochemical characteristic of 3 cases.

A Taraszewska1, H Kroh, A Majchrowski.   

Abstract

Three cases of subependymal giant cell astrocytoma (SEGA) in the women aged 23, 26, and 36 years were reported. Two of them had no clinical evidence of tuberous sclerosis complex (TSC) and the one woman presented apparent mental retardation. All patients manifested sudden clinical onset with symptoms of elevated intracranial pressure due to tumor of lateral ventricles and obstructive hydrocephalus. At surgery, the neoplasm was removed totally in one case and resected partially in 2 cases. Histologically, the tumors were composed of large polygonal cells with vesicular nuclei, prominent nucleoli and glassy eosinophilic cytoplasm, intermingled with spindle and small cells. In addition, multinucleated and bizarre giant cells were present, but they were very numerous in one case only. The tumor cells revealed in all cases variegated immunoreactivity for glial fibrillary acidic protein (GFAP), S-100 protein, vimentin (VIM) and neuron-specific enolase (NSE), with stronger expression of VIM than GFAP in 2 cases. Immunostaining of neurofilament proteins and synaptophysin was negative. The results suggest rather astroglial incomplete or aberrant differentiation and maturation than neuronal differentiation of tumor cells. The immunohistochemical variations of SEGA in asymptomatic TSC cases and those associated with tuberous sclerosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9595853

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  5 in total

1.  A case of solitary subependymal giant cell astrocytoma with histopathological anaplasia and TSC2 gene alteration.

Authors:  Mario Suzuki; Akihide Kondo; Ikuko Ogino; Osamu Akiyama; Naohide Fujita; Yuzaburo Shimizu; Hajime Arai
Journal:  Childs Nerv Syst       Date:  2020-07-29       Impact factor: 1.475

Review 2.  A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.

Authors:  David M Feliciano; Tiffany V Lin; Nathaniel W Hartman; Christopher M Bartley; Cathryn Kubera; Lawrence Hsieh; Carlos Lafourcade; Rachel A O'Keefe; Angelique Bordey
Journal:  Int J Dev Neurosci       Date:  2013-02-26       Impact factor: 2.457

Review 3.  A case of subependymal giant cell astrocytoma without tuberous sclerosis complex and review of the literature.

Authors:  Michael O'Rawe; Arjun S Chandran; Stuti Joshi; Alexandre Simonin; Jason M Dyke; Sharon Lee
Journal:  Childs Nerv Syst       Date:  2020-08-17       Impact factor: 1.475

Review 4.  Subependymal giant cell astrocytoma (SEGA): a case report and review of the literature.

Authors:  Layla Tahiri Elousrouti; Meryem Lamchahab; Nawal Bougtoub; Hinde Elfatemi; Laila Chbani; Taoufik Harmouch; Mustapha Maaroufi; Afaf Amarti Riffi
Journal:  J Med Case Rep       Date:  2016-02-09

5.  Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.

Authors:  Kyoichi Tomoto; Ayataka Fujimoto; Chikanori Inenaga; Tohru Okanishi; Shin Imai; Masaaki Ogai; Akiko Fukunaga; Hidenori Nakamura; Keishiro Sato; Akira Obana; Takayuki Masui; Yoshifumi Arai; Hideo Enoki
Journal:  BMC Neurol       Date:  2021-03-31       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.